Navigation path

HOME
Policy areas
Sectors
Who is in charge?
Competition and you
Cases
What's new? | Manuals | Contact

39685 Fentanyl

Companies: Janssen-Cilag BV / Johnson & Johnson / Novartis / Sandoz BV
Economic Activity: C.21.20 - Manufacture of pharmaceutical preparations
G.46.46 - Wholesale of pharmaceutical goods
Events:
Date Document Type Document
29.04.2015 Second Advisory Committee Second Advisory Committee:
Multilingual
29.04.2015 Report of the Hearing Officer Final Report of the Hearing Officer:
Multilingual
29.04.2015 Summary Decision Summary of the Decision:
Multilingual
29.04.2015 First Advisory Committee First Advisory Committee:
Multilingual
10.12.2013 Prohibition Decision (Art. 101 Ex 81) en pdf  Published on 05.03.2015
10.12.2013 No Public Version available en pdf
10.12.2013 Press Release Commission fines Johnson & Johnson and Novartis € 16 million for delaying market entry of generic pain-killer fentanyl:
en
31.01.2013 Press Release Commission sends Statement of Objections to J&J and Novartis on delayed entry of generic pain-killer:
en
21.10.2011 Press Release Commission opens proceedings against Johnson & Johnson and Novartis:
en
18.10.2011 Opening of Proceedings en pdf
These publications are for information purposes only and should not be considered as an official publication

New Search